ZNF33A Promotes Tumor Progression and BET Inhibitor Resistance in Triple-Negative Breast CancerXu Wang(Fudan University), Peng Xing(First Hospital of China Medical University)American Journal Of PathologyJuly 16, 202210.1016/j.ajpath.2022.06.010Cited by 5SaveCiteExport RISWatch citationsRelated PapersSNX10‐mediated LPS sensing causes intestinal barrier dysfunction via a caspase‐5‐dependent signaling cascade|The EMBO Journal|2021|72